Does achieving an SBP of 130 mmHg or less reduce cardiovascular risk or mortality compared to an SBP of 131 to 141 mmHg in hypertensive patients?
Achieving a lower SBP (≤130 mmHg) in hypertensive patients may be associated with increased mortality compared to moderate control (131-141 mmHg), highlighting the need for randomized trials on aggressive targets.
Achieved SBP 130 mmHg or less is not associated with lower cardiovascular risk than SBP of 131 to 141 mmHg and is associated with a significantly increased risk of death and trend towards increased cardiovascular mortality. These findings support the need for randomized evaluation of treatment to more aggressive vs. conventional SBP targets.
Okin et al. (Thu,) studied this question.